ANI Pharmaceuticals, Inc. (ANIP)

Last Closing Price: 61.43 (2024-05-17)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ANI Pharmaceuticals, Inc. (ANIP) had Net Income of $17.15M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$486.82M
Net Income
$17.15M
$181.51M
$305.30M
$439.85M
$46.97M
$-27.10M
$19.87M
$19.87M
$18.78M
$18.78M
$18.78M
$18.78M
$46.97M
$106.76M
18.00M
18.19M
$0.86
$0.85
Balance Sheet Financials
$519.82M
$44.59M
$384.61M
$904.42M
$145.48M
$284.82M
$301.35M
$446.82M
$432.75M
$220.37M
$457.60M
20.48M
Cash Flow Statement Financials
$118.96M
$-18.51M
$67.44M
$53.23M
$221.12M
$167.89M
$20.65M
--
$-1.62M
Fundamental Metrics & Ratios
3.57
--
--
0.38
0.62
62.71%
9.65%
9.65%
21.93%
4.08%
3.52%
$110.09M
--
--
--
0.54
1.63
3.00
121.52
4.34%
8.52%
2.08%
2.53%
$22.35
$6.05
$6.54